Mumbai: Novartis India Ltd, the Indian subsidiary of Swiss drug maker Novartis AG, on Thursday reported a 17% growth in profit to Rs33.3 crore for the quarter ended 30 September, against Rs29.2 crore in the corresponding period last fiscal. Sales grew 4.6% from the year-ago period to Rs161.5 crore. The company, which makes and markets prescription drugs, animal healthcare products, and consumer health businesses and consumer health products that comprise over-the-counter (OTC) drugs, posted sales in all segments except the OTC unit. Novartis’ share price fell 2.03% to close at Rs522.65 on the Bombay Stock Exchange on Thursday. The benchmark Sensex dropped 1.42% to 16,053.72 points.